MN

Mudassar Nazar

Active Director Director DIN 06904356
DIN 06904356 First appointment Sep 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2015
Shareholding value •••• Premium profile

About Mudassar Nazar

Data last updated:

Mudassar Nazar is a Director at Convex Pharma Private Limited (since 2015). The company operates in Trading. Convex Pharma Private Limited reported revenue of ₹10.7 Lakh (FY 2022).

DIN 06904356
Primary Designation Director
Industry Trading
First Appointment 17 Sep 2015
Oldest Company Age 12 yrs
Largest company Convex Pharma Private Limited · ₹10.7 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Convex Pharma Private Limited U74120UP2014PTC065775
Director17 Sep 20152014₹10.7 Lakh (FY 2022)Active

Board colleagues of Mudassar Nazar

NameDINCompanyDesignation
Ravi Shanker06904370Convex Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Convex Pharma Private Limited
Premium access

Shareholding and investment profile for Mudassar Nazar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mudassar Nazar

Mudassar Nazar currently holds 1 directorship: Convex Pharma Private Limited (Director, since 17 Sep 2015, revenue ₹10.7 Lakh (FY 2022)).

Mudassar Nazar was first appointed on 17 Sep 2015 as Director at Convex Pharma Private Limited.

The current boards of Mudassar Nazar's companies include Ravi Shanker (Convex Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available